NALDEMEDINE TOSYLATE (Rizmoic®)
Clinical Indication
opioid-induced constipation
Date of classification
November 2019
Green
Medicines which could be started in any health care setting and do not require oversight by a specialist and which primary care would have full responsibility for prescribing and monitoring.